Company Profile
Orum Therapeutics
Company Overview
Orum Therapeutics is pioneering precision delivery of targeted protein degraders for the development of oncology treatments.
Orum Therapeutics is a private biotech developing next-generation TPD technologies. Orum's novel and proprietary next generation targeted protein degradation (TPD) platform, TPD2 AnDC (Antibody neoDegrader Conjugate), enables tumor-specific targeting for multiple indications. Orum was founded in 2016 and has labs and offices operating out of Daejeon, South Korea, and Cambridge, MA, US.
Benefits
Flexible Work Schedule, Hybrid work environment, Parking/Commuter passes.